About US
Contact us
-
Novartis reports positive results from breast cancer drug trialA Phase III study carried out by Novartis has demonstrated that Afinitor (everolimus) tablets coupled with exemestane can more than double the time women with breast cancer live without tumour growth.2011/9/30
-
SHL to Speak at the Upcoming Drug Delivery Trends Symposium in KoreaSHL marketing director Steven Kaufman will be speaking at the upcoming Primary Packaging and Drug Delivery Trends for Injectables symposium held by Pharmapack Symposium in Seoul, Korea on 14 October 22011/9/30
-
SFDA Commissioner Shao Mingli meets Deputy Minister of the Syrian Ministry of HealthOn the morning of September 23, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA) met with the visiting Dr. Rajwa Jbeily, Deputy Minister of the Syrian Ministry of Healt2011/9/29
-
Novartis files for European Marketing Authorisation for Seebri BreezhalerNovartis has filed for European marketing authorisation of its chronic obstructive pulmonary disease treatment, Seebri Breezhaler. The filing follows new Phase III data, presented by Novartis at the2011/9/29
-
SFDA further specifies relevant requirements on record filing and change of authorized registration responsible agent in China for administrative licensing of imported cosmeticsThe State Food and Drug Administration (SFDA) recently issued a notice to further specify relevant requirements on record filing and change of authorized registration responsible agent in China for ad2011/9/28
-
SFDA further specifies requirements for application documents of cosmetics administrative licensingIn order to further standardize the application of cosmetics administrative licensing, the State Food and Drug Administration (SFDA) recently issued a notice, which further specified relevant requirem2011/9/28
-
New insights into actions of NSAIDsIbuprofen, naproxen, and related non-steroidal anti-inflammatory drugs (NSAIDs) - the subjects of years of study - still have some secrets to reveal about how they work. Vanderbilt University inves2011/9/27
-
Sodium Stibogluconate & Paromomycin combination treatment for Kala azarUrgent support needed for governments to roll out treatments and control disease East Africa is fighting the worst kala azar outbreak in a decade. Collaboration across the region through the Leishman2011/9/26
-
Johnson & Johnson resumes Tylenol shipmentsJohnson & Johnson has resumed shipping its Tylenol Cold and Flu Severe caplets, made by McNeil Consumer Healthcare, more than a year after the product was recalled due to manufacturing deficien2011/9/23
-
Guide for Medical Device Adverse Event Monitoring (interim) issuedIn order to intensify the monitoring of medical device adverse event, the State Food and Drug Administration formulated the Guide for Medical Device Adverse Event Monitoring (interim) in accordance wi2011/9/23